The price list of the targeted drug Aceminib in 2024 has been announced

Asciminib (Asciminib) is a member of the BCR-ABL tyrosine kinase inhibitor class of drugs and is commonly used to treat chronic myelogenous leukemia. Asiminib is a prescription drug used to treat adults with:Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+CML) in chronic phase (CP) who have been previously treated with 2 or more tyrosine kinase inhibitors (TKIs); or Ph+ chronic myelogenous leukemia with a T315I mutation. It is not known whether Asiminibis safe and effective in children.

Before taking Asiminib, you should tell your doctor about any medical conditions you have, which may include a history of inflammation of the pancreas (pancreatitis), a history of heart disease or blood clots in your arteries and veins (type of blood vessels), being pregnant or planning to become pregnant. Aceminix may harm an unborn baby. Aceminid may also cause serious side effects such as low blood cell counts, pancreatic problems, high blood pressure, allergic reactions, cardiovascular problems, etc. If a patient experiences certain side effects, the doctor may change the dose used, temporarily stop or permanently stop Aceminid treatment.

The original drug of Asiminib has not yet been launched in China, so it cannot be included in the medical insurance. The original drug of Asiminib sold overseas is very expensive. The price of 20mg*60 oral tablets is about more than 20,000 US dollars, which is about 150,000 yuan in RMB. There are also Assimini generic drugs produced and marketed overseas, and their drug ingredients are basically the same as those of the original drug. For example, the price of 40mg*60 tablets produced by a Laos pharmaceutical factory may be more than 4,000 yuan per box (the price may fluctuate due to exchange rates). The price is relatively cheap. For more information about overseas drugs and specific prices, please consult Yaode Medical Consultant.